Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency

NCT07643818 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

150

Enrollment

OTHER_GOV

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction (HFpEF

Interventions

DRUG: Ferric Derisomaltose
DRUG: Placebo

Sponsor

Government of Jersey

Collaborators

[object Object]